From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|CAS Registry Number|
|Synonyms||Endiemal, metharbitone, methobarbitone|
|Molecular mass||198.219 g/mol|
|(what is this?)|
Metharbital was patented in 1905 by Emil Fischer working for Merck. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.
- 1952 Gemonil was introduced by Abbott Laboratories.
- 1990 Abbott stopped marketing.
- The Comparative Toxicogenomics Database: Metharbital
- US Patent 782742
- The Treatment of Epilepsy 2nd Ed by S. D. Shorvon (Editor), David R. Fish (Editor), Emilio Perucca (Editor), W. Edwin Dodson (Editor). Published by Blackwell 2004. ISBN 0-632-06046-8
- The Medical Treatment of Epilepsy by Stanley R Resor. Published by Marcel Dekker (1991). ISBN 0-8247-8549-5
- A. Halpern, J.W. Jones, J. Am. Pharm. Assoc., 38, 352 (1949)
- Snyder, J. A.; Link, K. P. (1953). "Preparation and Characterization by Alkaline Methanolysis of 5,5-Diethyl-4-(tetraacetyl-β-D-glucosyloxy)-2,6(1,5)-pyrimidinedione". Journal of the American Chemical Society 75 (8): 1881. doi:10.1021/ja01104a030.
- U.S. Patent 782,742
|This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it.|